» Articles » PMID: 21437214

Exploring Airway Diseases by NMR-based Metabonomics: a Review of Application to Exhaled Breath Condensate

Overview
Specialty Biology
Date 2011 Mar 26
PMID 21437214
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

There is increasing evidence that biomarkers of exhaled gases or exhaled breath condensate (EBC) may help in detecting abnormalities in respiratory diseases mirroring increased, oxidative stress, airways inflammation and endothelial dysfunction. Beside the traditional techniques to investigate biomarker profiles, "omics" sciences have raised interest in the clinical field as potentially improving disease phenotyping. In particular, metabonomics appears to be an important tool to gain qualitative and quantitative information on low-molecular weight metabolites present in cells, tissues, and fluids. Here, we review the potential use of EBC as a suitable matrix for metabonomic studies using nuclear magnetic resonance (NMR) spectroscopy. By using this approach in airway diseases, it is now possible to separate specific EBC profiles, with implication in disease phenotyping and personalized therapy.

Citing Articles

Exhaled Breath Analysis: From Laboratory Test to Wearable Sensing.

Heng W, Yin S, Chen Y, Gao W IEEE Rev Biomed Eng. 2024; 18:50-73.

PMID: 39412981 PMC: 11875904. DOI: 10.1109/RBME.2024.3481360.


Ethanol Decreases Pseudomonas aeruginosa Flagellar Motility through the Regulation of Flagellar Stators.

Lewis K, Baker A, Chen A, Harty C, Kuchma S, OToole G J Bacteriol. 2019; 201(18).

PMID: 31109994 PMC: 6707923. DOI: 10.1128/JB.00285-19.


Towards precision medicine: The application of omics technologies in asthma management.

Scelfo C, Galeone C, Bertolini F, Caminati M, Ruggiero P, Facciolongo N F1000Res. 2018; 7:423.

PMID: 29904594 PMC: 5964625. DOI: 10.12688/f1000research.14309.2.


Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Giddings O, Esther Jr C Pediatr Pulmonol. 2017; 52(S48):S21-S28.

PMID: 28714611 PMC: 5664212. DOI: 10.1002/ppul.23768.


Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics.

Zang X, Perez J, Jones C, Monge M, McCarty N, Stecenko A J Am Soc Mass Spectrom. 2017; 28(8):1489-1496.

PMID: 28364225 DOI: 10.1007/s13361-017-1660-9.


References
1.
Saude E, Obiefuna I, Somorjai R, Ajamian F, Skappak C, Ahmad T . Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance. Am J Respir Crit Care Med. 2008; 179(1):25-34. DOI: 10.1164/rccm.200711-1716OC. View

2.
Kharitonov S, Barnes P . Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001; 163(7):1693-722. DOI: 10.1164/ajrccm.163.7.2009041. View

3.
Baker E, Clark N, Brennan A, Fisher D, Gyi K, Hodson M . Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis. J Appl Physiol (1985). 2007; 102(5):1969-75. DOI: 10.1152/japplphysiol.01425.2006. View

4.
Czebe K, Barta I, Antus B, Valyon M, Horvath I, Kullmann T . Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations. Respir Med. 2008; 102(5):720-5. DOI: 10.1016/j.rmed.2007.12.013. View

5.
Chladkova J, Krcmova I, Chladek J, cap P, Micuda S, Hanzalkova Y . Validation of nitrite and nitrate measurements in exhaled breath condensate. Respiration. 2006; 73(2):173-9. DOI: 10.1159/000088050. View